Colo-rectal Cancer Management - Biological Therapy
Colo-rectal Cancer Management - Biological Therapy
Biological therapy causes fewer side effects than chemotherapy drugs.Cancer cells are different from normal cells. Biological or Targeted therapies make use of this principle to attack cancer cells. Because of this, they should cause fewer side effects than chemotherapy drugs.
The medications used in this therapy are:
- Cetuximab
- Panitumumab
- Bevacizumab
Bevacizumab is another monoclonal antibody, approved for first-line use against metastatic colorectal cancer. It is used along with chemotherapy drugs. This antibody is directed against vascular endothelial growth factor (VEGF), a protein that helps tumors form new blood vessels.
Clinical trials are in progress to study different combinations of chemotherapy agents and targeted therapies.
References:
- Colorectal Cancer-Patient Version - (http://www.cancer.gov/cancertopics/types/colon-and-rectal)
- Colorectal Cancer - (http://www.nlm.nih.gov/medlineplus/colorectalcancer.html)
Cite this Article ⇣⇡
Please use one of the following formats to cite this article in your essay, paper or report:
-
APA
Dr. Anitha Paderla. (2020, July 07). Colo-rectal Cancer Management - Biological Therapy. Medindia. Retrieved on Jan 04, 2025 from https://www.medindia.net/health/conditions/colorectal-cancer-management-biological.htm.
MLA
Dr. Anitha Paderla. "Colo-rectal Cancer Management - Biological Therapy". Medindia. Jan 04, 2025. <https://www.medindia.net/health/conditions/colorectal-cancer-management-biological.htm>.
Chicago
Dr. Anitha Paderla. "Colo-rectal Cancer Management - Biological Therapy". Medindia. https://www.medindia.net/health/conditions/colorectal-cancer-management-biological.htm. (accessed Jan 04, 2025).
Harvard
Dr. Anitha Paderla. 2020. Colo-rectal Cancer Management - Biological Therapy. Medindia, viewed Jan 04, 2025, https://www.medindia.net/health/conditions/colorectal-cancer-management-biological.htm.